This research briefing describes recent work at the University of Cambridge on kidney cancer screening, led by Dr Juliet Usher-Smith and Professor Grant Stewart. Kidney cancer is the 7th most common cancer in the UK and the incidence is projected to rise by 26% between 2014 and 2035, representing one of the fastest accelerating cancers […]
New study finds bowel screening based on risk of disease, not age alone, could save lives
Using estimated individual risk of bowel cancer in England to determine when people should start being screened for the disease, may result in fewer bowel cancer cases and deaths. The findings are from a study led by Dr Juliet Usher-Smith (Prevention Group, Primary Care Unit) and Dr Chloe Thomas (University of Sheffield), funded by Bowel […]
Research Alert: Improving screening for bowel cancer using risk stratification
Age is the most important risk factor for bowel cancer but many genetic and lifestyle risk factors have been identified. There is interest in whether information about these factors could be used to improve screening programmes for bowel cancer. See this article as a shareable feature In research funded by Bowel Cancer UK and led […]
NIHR awards for Dr Hannah Harrison and Dr Juliet Usher-Smith
Dr Hannah Harrison was awarded an NIHR Development and Skills Enhancement Award in October 2020 Hannah, Research Associate at the Prevention Group, aims to use her Fellowship to further develop her skills in risk model development and public health modelling. Building on previous work identifying and validating risk models for the development of kidney cancer, […]
New research finds public enthusiastic about kidney cancer screening
In this guest blog, Laragh Harvey-Kelly, a final-year medical student at the University of Cambridge, explains her recently published work on public attitudes to kidney cancer screening. She undertook this research as part of a Student Selected Component supervised by Dr Juliet Usher-Smith. Kidney cancer is on the rise and is projected to increase over […]
Current evidence on screening for renal cancer
Renal cell carcinoma (RCC) rates are increasing worldwide, with high mortality and a high proportion of patients asymptomatic at diagnosis – so should we be screening for RCC? Patients with kidney cancer, their caregivers and clinicians alike, define the study of early detection and treatment of RCC as one of their top research priorities. The […]